The new analysis looked at non-small-cell lung cancer, by far the most common type.

It was being tested against non-small-cell lung cancer, the most common form of the disease.

Future directions in the treatment of non-small-cell lung cancer.

Vinorelbine is approved for the treatment of non-small-cell lung cancer.

Non-small-cell lung cancer grows more slowly and is more common.

Non-small-cell lung cancer is assigned a stage of 1 through 4, depending on how far it has spread.

The patients all had early stages of non-small-cell lung cancer, the most common form of the disease.

The study looked at 154 patients who had early-stage surgery to treat non-small-cell lung cancer.

The drug underwent clinical trials as a potential targeted treatment for non-small-cell lung cancer.

The effect was most pronounced for so-called non-small-cell lung cancer, the most common form in women.

Drug delivery analysis of the Canadian multicenter trial in non-small-cell lung cancer.

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer.

Non-small-cell lung cancer can also be treated with erlotinib or gefitinib.

About 85 percent of lung cancer cases are non-small-cell lung cancer.

When non-small-cell lung cancer is found before it spreads beyond one lung, surgery can sometimes help.

A study of postoperative radiotherapy in patients with non-small-cell lung cancer: A randomized trial.

It may also serve as a potential molecular marker for detection of micrometastasis in non-small-cell lung cancer.

Aspects of diagnosing and staging of non-small-cell lung cancer (letter).

About 1 percent to 7 percent of patients with non-small-cell lung cancer have an abnormal gene that causes tumor growth.

Bavituximab is being developed to treat second-line non-small-cell lung cancer and multiple other cancers.

Vinorelbine-used to treat breast cancer and non-small-cell lung cancer.

Decision framework for chemotherapeutic interventions for metastatic non-small-cell lung cancer.

Pfizer’s crizotinib attacks a protein encoded by a gene found in fewer than 5% of patients with non-small-cell lung cancer.

Phase II trial of 13-cis-retinoic acid plus interferon alpha in non-small-cell lung cancer.

Chemotherapy vs supportive care in advanced non-small-cell lung cancer: results of a meta-analysis of the literature.